Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis (Q80146906)
Jump to navigation
Jump to search
scientific article published on 06 December 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis |
scientific article published on 06 December 2007 |
Statements
Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis (English)
E Atallah
R Nussenzveig
C C Yin
C Bueso-Ramos
T Manshouri
S Pierce
H Kantarjian
6 December 2007